Warning: The NCBI web site requires JavaScript to function. more...
IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life.
Kinyanjui SM, Conway DJ, Lanar DE, Marsh K.
Malar J. 2007 Jun 28;6:82.
Related citations
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.
Infect Immun. 2009 Mar;77(3):1165-74. Epub 2009 Jan 12.
Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.
Reilly L, Magkrioti C, Mduluza T, Cavanagh DR, Mutapi F.
BMC Infect Dis. 2008 Nov 17;8:158.
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K.
Infect Immun. 2008 May;76(5):2240-8. Epub 2008 Mar 3.
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.
Iriemenam NC, Khirelsied AH, Nasr A, ElGhazali G, Giha HA, Elhassan A-Elgadir TM, Agab-Aldour AA, Montgomery SM, Anders RF, Theisen M, Troye-Blomberg M, Elbashir MI, Berzins K.
Vaccine. 2009 Jan 1;27(1):62-71. Epub 2008 Oct 31.
Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P.
Infect Immun. 2006 May;74(5):2887-93.
Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.
Akpogheneta OJ, Dunyo S, Pinder M, Conway DJ.
Parasite Immunol. 2010 Apr;32(4):296-304.
Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons.
Omosun YO, Anumudu CI, Adoro S, Odaibo AB, Sodeinde O, Holder AA, Nwagwu M, Nwuba RI.
Acta Trop. 2005 Sep;95(3):233-47.
Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.
Woodberry T, Minigo G, Piera KA, Hanley JC, de Silva HD, Salwati E, Kenangalem E, Tjitra E, Coppel RL, Price RN, Anstey NM, Plebanski M.
J Infect Dis. 2008 Jul 1;198(1):134-42.
Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya.
Chelimo K, Ofulla AV, Narum DL, Kazura JW, Lanar DE, John CC.
Pediatr Infect Dis J. 2005 Aug;24(8):680-4.
Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India.
Lucchi NW, Tongren JE, Jain V, Nagpal AC, Kauth CW, Woehlbier U, Bujard H, Dash AP, Singh N, Stiles JK, Udhayakumar V.
Malar J. 2008 Jul 4;7:121.
The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria.
Courtin D, Oesterholt M, Huismans H, Kusi K, Milet J, Badaut C, Gaye O, Roeffen W, Remarque EJ, Sauerwein R, Garcia A, Luty AJ.
PLoS One. 2009 Oct 27;4(10):e7590.
Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, Marsh K.
Parasite Immunol. 2007 Aug;29(8):387-94.
Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium.
Mutapi F, Roussilhon C, Mduluza T, Druilhe P.
Mem Inst Oswaldo Cruz. 2007 Jun;102(3):405-9.
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
Roussilhon C, Oeuvray C, Müller-Graf C, Tall A, Rogier C, Trape JF, Theisen M, Balde A, Pérignon JL, Druilhe P.
PLoS Med. 2007 Nov 13;4(11):e320.
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
Metzger WG, Okenu DM, Cavanagh DR, Robinson JV, Bojang KA, Weiss HA, McBride JS, Greenwood BM, Conway DJ.
Parasite Immunol. 2003 Jun;25(6):307-12.
Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.
Zhou Z, Xiao L, Branch OH, Kariuki S, Nahlen BL, Lal AA.
Am J Trop Med Hyg. 2002 Jan;66(1):7-12.
A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.
Fonjungo PN, Elhassan IM, Cavanagh DR, Theander TG, Hviid L, Roper C, Arnot DE, McBride JS.
Infect Immun. 1999 Jun;67(6):2975-85.
Variant-specific antibodies to merozoite surface protein 2 and clinical expression of Plasmodium falciparum malaria in rural Amazonians.
Scopel KK, da Silva-Nunes M, Malafronte RS, Braga EM, Ferreira MU.
Am J Trop Med Hyg. 2007 Jun;76(6):1084-91.
Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.
Arnot DE, Cavanagh DR, Remarque EJ, Creasey AM, Sowa MP, Morgan WD, Holder AA, Longacre S, Thomas AW.
Clin Vaccine Immunol. 2008 Sep;15(9):1345-55. Epub 2008 Jun 11.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on